Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Derita warga sekitar PLTS Cirata: Bak layangan putus tanpa kepastian sumber nafkah

● Kompleks PLTS Cirata merupakan salah satu proyek transisi energi terbesar nasional.● Sayangnya euforia realisasi pembangunan proyek transisi energi besar itu menyisakan kisah kelam di ba...

Teror aktivis HAM kian ganas dan meluas, inikah saatnya PBB lebih serius memantau Indonesia?

Astrichairina/Shutterstock● Kasus penyiraman air keras Andrie Yunus menunjukkan ruang sipil Indonesia menjadi arena berbahaya.● Pembela HAM kembali menghadapi periode ancaman teror dan lab...

Inovasi layanan dan produk berbasis AI perbankan jadi fondasi melejitnya sistem pembayaran nasional

● Indonesia memang jadi raja ekonomi digital di kawasan Asia Tenggara.● Untuk sektor pembayaran digital, Indonesia masih kalah saing.● Perbankan memainkan peranan penting untuk mendo...